International Society of Pharmacovigilance

What International Society of Pharmacovigilance does

The International Society of Pharmacovigilance (ISoP) is a private, non-profit scientific organization founded in 2000 (with roots in the European Society of Pharmacovigilance, established 1992) and headquartered in London, UK. It functions as a global learned society dedicated to advancing the science and practice of pharmacovigilance (drug safety), serving individual professionals and institutional members across the pharmaceutical industry, national regulatory authorities, contract research organizations, academia, public hospitals, and students. The society operates a largely virtual organization model with 14 regional chapters (Africa, China, Egypt, Europe, Indonesia, Italy, Latin America, MENA, Middle East, North America/NASoP, South Asia, Switzerland, UK & Ireland, Western Pacific) and 16+ Special Interest Groups (SIGs) covering topics from Risk Communication to AI in Pharmacovigilance.

ISoP's core products include tiered annual memberships (Standard €249, Reduced €99, Special Reduced €49), the official Drug Safety journal access, a structured training curriculum (including the WHO-ISoP PV Curriculum and IA Seminars on Intelligent Automation running since 2017), the annual global meeting (2024 Montreal, 2025 Cairo, 2026 San José), mid-year symposia, and Patient Safety Day events. The technology stack is conventional: a WordPress website with Stripe payment processing, Google Analytics, YouTube channel, and social media engagement; the underlying value is not proprietary technology but a curated community and content library.

ISoP generates revenue through membership subscriptions, paid annual meetings and mid-year symposia, training courses (including the Eu2P/Am2P academic-accredited programs), and the joint Drug Safety journal partnership. Pricing is tiered by World Bank country income classification (HIC vs. LMIC) and organization type (commercial vs. not-for-profit), making the offering accessible globally. The society is member-funded with no disclosed external investment, no parent company, and no subsidiaries, governed by an elected Executive Committee and Advisory Board.

Name

International Society of Pharmacovigilance

Legal name

International Society of Pharmacovigilance

Website

https://isoponline.org

Company type

Private

Founded year

2000

Operating status

Operating

Headcount range

11–50 employees

Short description

ISoP is a global, member-funded non-profit scientific society advancing pharmacovigilance (drug safety) across 108+ countries. It serves 1,500+ professionals from industry, regulators, academia, and healthcare through tiered memberships, 14 regional chapters, 16+ Special Interest Groups, and the Drug Safety journal.

Ownership category

akta.pro rank

Headquarters

HQ city

London

HQ country

United Kingdom

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B and B2C

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Technology or R&D, Others

Revenue model

1. Membership Subscriptions: Annual membership fees providing tiered access (Standard €249, Reduced €99, Special Reduced €49). All memberships are automatically renewing annual subscriptions.
2. Annual Meeting Fees: Reduced fees for ISoP Annual Meetings for members.
3. Training Courses and Seminars: Reduced fees for ISoP Meetings, Training courses and online courses (Eu2P/Am2P). Mid-year symposia and IA seminars (Boston) generate revenue.
4. Drug Safety Journal Access: Online access to Drug Safety journal included with membership.

Pricing tiers

Go-to-market motion1 record

Distribution channels4 records

Marketing channels8 records

Core offering

ISoP is an international non-profit scientific organization that delivers membership-based services to pharmacovigilance professionals worldwide. Its core offerings are tiered annual memberships (Standard €249, Reduced €99, Special Reduced €49) that bundle access to the Drug Safety journal, training courses, annual meetings, mid-year symposia, IA Seminars on Intelligent Automation in Pharmacovigilance, Patient Safety Day events, 14 regional chapters, and 16+ Special Interest Groups covering topics such as AI in Pharmacovigilance, Risk Communication, Vaccine Surveillance, and Patient Engagement.

Product overview

ISoP operates as a professional society offering a membership-based platform with multiple interconnected products and services. The core offering is the ISoP Membership (three tiers: Standard €249, Reduced €99, Special Reduced €49) which provides access to the Drug Safety journal, webinars, training courses, and annual meetings. The portfolio includes structured training through Mid-Year Symposiums, ISoP IA Seminars (focusing on Intelligent Automation since 2017), and Patient Safety Day events. Members also gain access to 14 geographically-based Chapters and 16 Special Interest Groups covering specialized areas including AI in Pharmacovigilance. The Eu2P/Am2P Collaboration extends the offering with accredited online courses. The Annual Meetings serve as flagship events, with the 25th Anniversary celebrated in 2025. The society acts as a hub connecting pharmacovigilance professionals across 118+ countries through education, networking, and research dissemination.

Differentiator

Problem solved

Functional benefit

Products and services

• ISoP Membership Annual membership providing access to the Drug Safety journal, webinars, training workshops, reduced-fee annual meetings, chapter networks, Special Interest Group participation, and archived Annual Meeting presentations. Three tiers available: Standard (€249), Reduced (€99), and Special Reduced (€49), with prices differentiated by country income classification and organization type.
• ISoP Annual Meetings Annual global conferences bringing together pharmacovigilance professionals worldwide, with reduced fees for members. Includes pre-conference training courses. ISoP 2026 in San José, Costa Rica; ISoP 2025 in Cairo, Egypt; ISoP 2024 in Montreal, Canada.
• ISoP Training Courses Comprehensive educational program including mid-year symposiums, pre-conference courses, basic and advanced pharmacovigilance courses (1-3 days), advanced courses on risk management and benefit-harm assessment, and ad hoc courses covering clinical trial safety, pharmacogenetics, immunopharmacovigilance, and ecopharmacovigilance.
• ISoP Mid-Year Symposium Annual training symposium held mid-year at various global locations, with the 2026 edition scheduled for Hatfield, UK focusing on 'Collaboration in Pharmacovigilance in an evolving information environment'.
• ISoP IA Seminars (Intelligent Automation in Pharmacovigilance) Annual advanced seminars held in Boston, USA focusing on intelligent automation in pharmacovigilance, with sessions on AI applications, automation, and intelligent systems for PV workflows.
• ISoP Patient Safety Day Annual global virtual event aligned with WHO World Patient Safety Day, featuring multi-regional sessions across time zones.
• Eu2P/Am2P Collaboration Partnership with European (Eu2P) and American (Am2P) Programs in Pharmacovigilance and Pharmacoepidemiology, offering online courses with academic accreditation targeting PV professionals in different regions.

Named customers7 records

Segments5 records

Ideal customer profiles4 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability2 records

Partnerships

Eight partnerships are on record, tiered core and minor.

• Council For International Organizations of Medical Sciences (CIOMS)coreStrategic or Co-development Partner · 22 June 2022ISoP is an International Member of CIOMS. Following elections on 22 June 2022, Dr. Manal Younus (ISoP Board member) was elected as CIOMS Executive Committee member. ISoP and CIOMS collaborate on pharmacovigilance glossary publications and guidelines.
• European Collaborative Action on Medication Errors and Traceability (ECAMET)coreStrategic or Co-development PartnerISoP is a member of the ECAMET Alliance. ECAMET focuses on medication errors and traceability across Europe, aligning with ISoP's Medication Errors SIG and patient safety mission.
• European Association for Clinical Pharmacology and Therapeutics (EACPT)minorStrategic or Co-development PartnerISoP is an affiliated organisation to EACPT, facilitating collaboration in clinical pharmacology and therapeutics across Europe.
• Eu2P (European Programme of Pharmacovigilance and Pharmacoepidemiology)coreStrategic or Co-development PartnerSince Eu2P's creation, ISoP has been supportive of the programme and is delighted to partner with Eu2P. Joint training courses available to members.
• Am2P (American Program in Pharmacovigilance)coreStrategic or Co-development PartnerISoP North America Chapter (NASoP) launched Am2P targeting North America medicines stakeholders with Eu2P academic accreditation.
• World Health Organization (WHO)coreStrategic or Co-development PartnerISoP collaborates with WHO on pharmacovigilance initiatives. Some annual meetings held beside WHO Programme for International Drug Monitoring meetings. WHO-ISoP curriculum developed for training.
• Uppsala Monitoring Centre (UMC)coreStrategic or Co-development PartnerISoP collaborates with UMC (WHO Collaborating Centre) on pharmacovigilance training, resources, and initiatives. Joint symposia and collaborations on PV Cycle (Arabic version) with Egypt Chapter.
• CIOMS Working GroupsminorStrategic or Co-development PartnerCollaboration on CIOMS publications including the CIOMS Cumulative Pharmacovigilance Glossary, CIOMS IX Guideline on Risk Minimization, and other pharmacovigilance guidance documents.

Scale indicators6 records

Recent moves8 records

Expansion highlights6 records

Direct peers

• European Association for Clinical Pharmacology and Therapeutics (EACPT): European clinical pharmacology society; ISoP is an affiliated organisation of EACPT. Comparable scientific society model with overlapping conferences and member base in clinical pharmacology and therapeutics.
• International Society for Pharmacoepidemiology (ISPE): International scientific membership society dedicated to pharmacoepidemiology — a closely adjacent discipline to pharmacovigilance. Overlapping membership base (PV professionals, regulatory scientists, academics), similar conference/training model, and joint interest in drug safety real-world evidence.
• American Society for Clinical Pharmacology & Therapeutics (ASCPT): US-based scientific membership society for clinical pharmacology and therapeutics with strong PV track content and an annual meeting. Comparable membership society model and adjacent content focus (drug safety, benefit-risk).
• Drug Information Association (DIA): Global neutral membership-based professional association serving professionals in drug development, regulatory, and pharmacovigilance. Most direct peer given overlapping mission, conferences, training, and membership model serving pharma/regulatory professionals worldwide.

Broad incumbents

• International Pharmaceutical Federation (FIP): Global federation of national pharmaceutical associations and pharmacists, covering pharmacy practice broadly. Peer due to international membership-society structure, advocacy role, and overlap with ISoP's patient-safety mission, though FIP's scope is much wider than PV.
• Royal Pharmaceutical Society: UK professional membership body for pharmacists. Comparable professional society/membership structure and training/credentialing offerings, though broader scope than ISoP's drug-safety niche.

Emerging players

• International Society of Drug Bulletins (ISDB): International network of independent drug bulletins promoting rational pharmacotherapy. Comparable non-profit membership federation structure and patient-safety orientation, with overlap in drug safety communication.
• Society for Clinical Trials: International membership organisation for clinical trial design and conduct. Partial overlap with ISoP's clinical-trial safety content and similar academic/scientific membership model, though more focused on trial methodology than post-marketing surveillance.

Regional players

• American College of Clinical Pharmacy (ACCP): US-focused professional society for clinical pharmacists with research and education programmes. Comparable member society and training model; geographically limited to North America and broader scope than ISoP's PV focus.

Others

• International Federation of Pharmaceutical Manufacturers & Associations (IFPMA): Global trade association representing the pharmaceutical industry. Adjacent rather than direct peer — ISoP serves individual PV professionals while IFPMA represents corporate interests, though both engage with WHO and address drug safety policy.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat5 records

Key risks5 records

Key highlights6 records

Customer concentration

• YouTubeyoutube.com/channel/UCo-jtROXZbiDk_1GLxzThzQ/videos
• Facebookfacebook.com/profile.php
• Xx.com/ISoPonline
• LinkedInlinkedin.com/company/isop-online

Revenue estimate

Valuation estimate

Number of profiles

Profiles13 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about International Society of Pharmacovigilance